Filing Details

Accession Number:
0001209191-13-022914
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-04-29 16:50:58
Reporting Period:
2013-04-23
Filing Date:
2013-04-29
Accepted Time:
2013-04-29 16:50:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Pharmaceuticals Inc. PCRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1134657 Luke Evnin C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-04-23 108,115 $30.00 1,169,789 No 4 S Indirect See Footnote
Common Stock Disposition 2013-04-24 6,303 $30.04 1,163,486 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 22,746 Direct
Footnotes
  1. This transaction was pursuant to a 10b5-1 Plan.
  2. The shares were sold as follows: 101,325 by MPM BioVentures IV-QP, L.P. ("BV IV QP"), 3,903 by MPM BioVentures IV GmbH & Co. Beteiligungs KG ("BV IV KG") and 2,887 by MPM Asset Management Investors BV4 LLC ("AM BV4"). MPM BioVentures IV GP LLC and MPM BioVentures IV LLC ("BV LLC") are the direct and indirect general partners of BV IV QP and BV IV KG and BV LLC is the manager of AM BV4. The Reporting Person is a member of BV LLC.
  3. The shares are held as follows: 1,096,401 by BV IV QP, 42,243 by BV IV KG and 31,145 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  4. The shares were sold as follows: 5,907 by BV IV QP, 228 by BV IV KG and 168 by AM BV4.
  5. The shares are held as follows: 1,090,494 by BV IV QP, 42,015 by BV IV KG and 30,977 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.